HUTCHMED (China) (HCM) Gains from Investment Securities (2020 - 2021)
HUTCHMED (China) (HCM) reported Gains from Investment Securities of $30.5 million for Q1 2021, up 7.93% year-over-year from $28.3 million in Q1 2020, and up 7.93% quarter-over-quarter from $28.3 million in Q1 2020.
HUTCHMED (China) (HCM) Gains from Investment Securities (2020 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has 2 years of Gains from Investment Securities data on file, last reported at $30.5 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | HUTCHMED (China) | 1.20 Bn | -269.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 30.51 Mn |
| Mar 31, 2021 | 30.51 Mn |
| Mar 31, 2020 | 28.27 Mn |
| Mar 31, 2020 | 28.27 Mn |